Topchoice Medical Co., Inc. (SHA:600763)
China · Delayed Price · Currency is CNY 37.41
+0.99 (2.72%)
May 29, 2026, 3:00 PM CST
Topchoice Medical Co. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 504.99 | 501.95 | 501 | 500.44 | 548.27 | 702.81 |
Depreciation & Amortization | 190.93 | 190.93 | 203.41 | 189.35 | 173.31 | 153.8 |
Other Amortization | 72.5 | 72.5 | 64.45 | 55.25 | 46.1 | 35 |
Loss (Gain) From Sale of Assets | 0.27 | 0.27 | -0.14 | - | 0.05 | 0.02 |
Asset Writedown & Restructuring Costs | 0.36 | 0.36 | 0.86 | 0.42 | 0.51 | 0.21 |
Loss (Gain) From Sale of Investments | -47.33 | -47.33 | -47.84 | -60.19 | -38.3 | -56.13 |
Provision & Write-off of Bad Debts | 11.35 | 11.35 | 3.17 | 1.75 | 1.67 | 1.29 |
Other Operating Activities | 133.16 | 122.82 | 114.15 | 131.85 | 117.71 | 109.25 |
Change in Accounts Receivable | -42.73 | -42.73 | -28.94 | -37.77 | -45.07 | -46.88 |
Change in Inventory | 10.22 | 10.22 | -3.74 | -1.9 | -2.55 | -2.68 |
Change in Accounts Payable | -3.78 | -3.78 | -37.3 | 71.22 | -122.12 | 36.97 |
Change in Other Net Operating Assets | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 |
Operating Cash Flow | 824.1 | 810.72 | 762.99 | 841.02 | 670.05 | 939.41 |
Operating Cash Flow Growth | 5.53% | 6.25% | -9.28% | 25.52% | -28.67% | 32.59% |
Capital Expenditures | -236.15 | -246.2 | -332.11 | -508.9 | -421.53 | -367.32 |
Sale of Property, Plant & Equipment | 2.15 | 2.15 | 2.02 | 0.01 | 0.62 | 0.02 |
Cash Acquisitions | -15 | -15 | -27.73 | - | - | - |
Divestitures | - | - | - | -0.03 | - | 131.95 |
Investment in Securities | 8.38 | 11.11 | -7.04 | -504.25 | -60.45 | -234.42 |
Other Investing Activities | -55.01 | -31.31 | -96.1 | -14.47 | -15.99 | -14 |
Investing Cash Flow | -295.62 | -279.24 | -324.97 | -887.63 | -497.35 | -483.77 |
Long-Term Debt Issued | - | 50 | 80 | 280 | - | - |
Long-Term Debt Repaid | - | -224.81 | -252.43 | -193.57 | -251.18 | -241.76 |
Net Debt Issued (Repaid) | -13.81 | -174.81 | -172.43 | 86.43 | -251.18 | -241.76 |
Repurchase of Common Stock | - | - | -30.1 | -1 | -99.99 | - |
Common Dividends Paid | -209.11 | -208.89 | -149.89 | -11.24 | -6.69 | -12.87 |
Other Financing Activities | -110.31 | -71.32 | -59.85 | -63.04 | -28.33 | -31.3 |
Financing Cash Flow | -333.23 | -455.02 | -412.28 | 11.15 | -386.19 | -285.93 |
Net Cash Flow | 195.25 | 76.46 | 25.74 | -35.46 | -213.5 | 169.71 |
Free Cash Flow | 587.96 | 564.52 | 430.88 | 332.13 | 248.52 | 572.09 |
Free Cash Flow Growth | 14.15% | 31.02% | 29.73% | 33.64% | -56.56% | 6.33% |
Free Cash Flow Margin | 20.11% | 19.38% | 14.99% | 11.67% | 9.14% | 20.57% |
Free Cash Flow Per Share | 1.31 | 1.26 | 0.96 | 0.74 | 0.55 | 1.27 |
Cash Income Tax Paid | 154.5 | 153.52 | 162.07 | 142.52 | 227.01 | 105.67 |
Levered Free Cash Flow | 365.91 | 330.95 | 375.96 | 331.44 | -199.6 | 365.3 |
Unlevered Free Cash Flow | 387.47 | 353.36 | 404.36 | 365.82 | -168.32 | 383.37 |
Change in Working Capital | -42.12 | -42.12 | -76.06 | 22.15 | -179.26 | -6.83 |